Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDER
Fierce Pharma
FDA solidifies leadership posts at CDER, CBER
Following a months-long interregnum at the U.S. Food and Drug Administration, the leadership pieces are again locking into place at the regulator.
Fraiser Kansteiner
Sep 9, 2026 9:00am
Fierce Pharma
CDER chief Høeg and CBER's Szarama exiting FDA posts
May 15, 2026 1:44pm
Can’t plausible mechanism principles apply to uniQure?
Apr 15, 2026 4:00am
Yet another CDER leadership shake-up—Chutes & Ladders
Dec 5, 2025 8:30am
FDA names Tracy Beth Høeg as acting head of drug center
Dec 4, 2025 4:03am
FDA proposes higher fees for ph. 1 trials conducted outside of US
Dec 3, 2025 5:19pm
